TRESCON
|
TRESCON Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.20 | 0.40 | 0.18 | 0.27 | 0.50 |
| CEPS(Rs) | 0.21 | 0.40 | 0.18 | 0.30 | 0.58 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 15.36 | 15.16 | 14.76 | 14.58 | 14.34 |
| Tax Rate(%) | 43.89 | 15.98 | 22.86 | 42.51 | 14.54 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | - | - | -64.56 | -18.13 | - |
| EBIT Margin(%) | - | - | 137.91 | 101.61 | - |
| Pre Tax Margin(%) | - | - | 137.25 | 93.43 | - |
| PAT Margin (%) | - | - | 105.88 | 53.72 | - |
| Cash Profit Margin (%) | - | - | 107.01 | 59.87 | - |
| Performance Ratios | |||||
| ROA(%) | 1.29 | 2.62 | 1.19 | 1.84 | 3.25 |
| ROE(%) | 1.31 | 2.66 | 1.22 | 1.98 | 3.68 |
| ROCE(%) | 2.36 | 3.15 | 1.58 | 3.59 | 4.38 |
| Asset Turnover(x) | - | - | 0.01 | 0.03 | - |
| Sales/Fixed Asset(x) | - | - | 1.03 | 2.36 | - |
| Working Capital/Sales(x) | - | - | 0.02 | 0.07 | - |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | - | 0.97 | 0.42 | 357.23 |
| Receivable days | - | - | 666.46 | 214.51 | - |
| Inventory Days | - | - | - | - | - |
| Payable days | -16.75 | - | 300.50 | 105.74 | - |
| Valuation Parameters | |||||
| PER(x) | 73.05 | 20.83 | 101.04 | 211.94 | 122.92 |
| PCE(x) | 69.32 | 20.79 | 99.97 | 190.18 | 107.15 |
| Price/Book(x) | 0.95 | 0.55 | 1.23 | 3.96 | 4.32 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | - | - | 106.06 | 113.38 | - |
| EV/Core EBITDA(x) | 39.31 | 17.38 | 76.28 | 97.01 | 84.00 |
| EV/EBIT(x) | 40.48 | 17.67 | 76.90 | 111.58 | 93.36 |
| EV/CE(x) | 0.95 | 0.55 | 1.20 | 3.78 | 3.89 |
| M Cap / Sales | - | - | 106.98 | 113.85 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | - | -100.00 | -66.65 | - | -99.98 |
| Core EBITDA Growth(%) | -22.45 | 104.73 | -60.32 | -11.01 | 475.49 |
| EBIT Growth(%) | -23.44 | 103.02 | -54.73 | -14.01 | 421.60 |
| PAT Growth(%) | -49.63 | 122.09 | -34.26 | -39.95 | 5,080.85 |
| EPS Growth(%) | -49.64 | 122.12 | -34.26 | -45.89 | 4,788.18 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.01 | 0.01 | 0.01 | 0.06 |
| Current Ratio(x) | 53.67 | 65.40 | 75.92 | 14.09 | 4.61 |
| Quick Ratio(x) | 49.24 | 65.40 | 75.92 | 14.09 | 4.61 |
| Interest Cover(x) | 66.15 | 3,047.64 | 209.03 | 12.43 | 8.76 |
| Total Debt/Mcap(x) | - | 0.01 | 0.01 | - | 0.01 |
Compare Financial Ratios of peers of TRESCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRESCON | ₹81.4 Cr | 3.5% | -10.5% | -26.5% | Stock Analytics | |
| INDRAYANI BIOTECH | ₹54.3 Cr | 2.9% | -14.6% | -73.7% | Stock Analytics | |
TRESCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRESCON | 3.5% |
-10.5% |
-26.5% |
| SENSEX | 0.8% |
0.2% |
-2% |
You may also like the below Video Courses
